Abstract
Protein energy malnutrition leading to growth failure is an inevitable consequence of chronic liver disease in childhood. Although the precise pathophysiology is not understood considerable progress has been made in understanding the mechanisms of fat malabsorption and protein turnover in liver disease.
There are many difficulties with the correct assessment of nutritional parameters in children with liver disease related to their abnormal body composition and energy expenditure and care needs to be taken with the interpretation on results.
The effects of malnutrition secondary to chronic liver disease are varied and include fat soluble vitamin deficiencies, generalised growth failure, impairment of gastrointestinal function, immunosuppression and hypotonia. It is now recognised that malnutrition is an important risk factor for liver transplantation and increases both mortality and morbidity.
Strategies to prevent or reverse malnutrition are now established and include the use of specific infant formulas based on low salt protein and an increased concentration of medium train triglyceride (50–70%).
Careful nutritional support in association with generous fat soluble vitamin supplementation may produce dramatic improvement in catch up weight gain but for those children in whom growth failure persists, the only management is liver transplantation.
Similar content being viewed by others
References
Silverberg M, Davison M. Nutritional requirements of infants and children with liver disease.Amer J Clin Nutr 1970; 23: 604–613.
Weber A, Roy CC. The malabsorption associated with chronic liver disease in children.Paediatrics 1972; 50: 73–83.
Cohen MI, Gartner LM. The use of medium-chain triglycerides in the management of biliary atresia.J Pediatr 1971; 79: 379–384.
Charlton CPJ, Buchanan E, Holden CEet al. Intensive enteral feeding in advanced cirrhosis: reversal of malnutrition without precipitation of hepatic encephalopathy.Arch Dis Child 1992; 67: 603–607.
Kaufmann SS, Murray ND, Wood RPet al. Nutritional suport for the infant with extrahepatic biliary atresia.J Pediatr 1987; 110: 679–686.
Morgan AG, Kelleher J, Walker BEet al. Nutrition in cryptogenic cirrhosis and chronic aggressive hepatitis.Gut 1976; 17: 113–118.
McCullough AJ, Mullen KD, Smanik EJet al. Nutritional therapy and liver disease.Gastroenterol Clinics N Amer 1989; 18: 619–643.
Glasgow JFT, Hamilton JR, Sass-Kortsak A. Fat absorption in congenital obstructive liver disease.Arch Dis Child 1973; 48: 601–607.
Waterlow JC. Note on the assessment and classification of portein energy malnutrition in children.Lancet 2: 87–89.
Kelly DA, Kaufman SS, Shaw Bet al. Risk factors in gastrointestinal complications in children after orthotopic liver transplantation.Gut 1988; 29: A1476–1477.
Carey M, Small DM, Bliss CM. Lipid digestion and absorption.Annual Reviews of Physiology 1983; 45: 651–677.
Badley BW, Murphy GM, Boucher IA, Sherlock S. Diminished micellar phase lipid in patients with chronic alcoholic liver disease and steatorrhoea.Gastroenterology 1970; 58: 781–789.
Swart GR, Zillikens MC, Van Vurre JK. Van den Berg JWO. Effect of late evening meal on nitorgne balance in patients with cirrhosis of the liver.Brit Med J 1989; 299: 1202–1203.
Glynn MJ, Powell-Tuck J, Reavely DAet al. High lipid parenteral nutrition improves portosystemic encephalopathy.J Parent Enteral Nutr 1988; 12: 457–461.
McKiernan PJ, Thomson JM, Dodge JAet al. Food energy requirements in biliary atresia.J Pediatr Gastro Nutr (In press).
Wilson SR, Amoroso P, Baker Aet al. Resting energy expenditure in children with liver disease.Proc Nutr Soc 1991; 50: 157A.
Shiau Y. Lipid digestion and absorption. In:Physiology of the Gastrointestinal Tract. Johnson LR ed. New York: Raven Press. 1987; 56: 1527–1556.
Glickman RM. Malabsorption and nutritional support. InClinics in Gastroenterology Sleisenger MH ed. 1983: 323–334.
Beath S, Johnson T, Willis Ket al. Superior absorption of medium chain triglycerides compared with conventional dietary long chain fats in children with chronic liver disease.Proc Nutr Soc 1993; 52: 252.
Gourley GR, Farrel PM, Odell G. Essential fatty acid deficiency after hepatic portoenterostomy for biliary atresia.Am J Clin Nutr 1982; 36: 1194–1199.
Beath S, Kelly DA, Booth IW. Essential fatty acid in babies with cholestatic liver disease.Gut 1993; S34: 8.
Spray CH, Beath SV, Willis KDet al. Docosohexanoeic acid (DHA) and visual function in children with fat malabsorption secondary to liver disease.Proc Nutr Soc 1995; in press.
Amedee-Manesme O, Furre HC, Alvarezfet al. Biochemical indicators of vitamin A depletionin children with cholestasis.Hepatology 1985; 6: 1143–1148.
Rosenblum JL, Keating JP, Prensky ALet al. Aprogressive neurologic syndrome in children with chronic liver disease.N Engl J Med 1981; 304: 503–508.
Daum F, Rosen JF, Roginsky Met al. 25-Hydroxycholecalciferol in the management of rickets associated with extra hepatic biliary atresia.J Pediatr 1976; 94: 1041–1043.
Roberts HR, Sederbaum AI. Liver and blood coagulation physiology and pathology.Gastroenterology 1972; 63: 297–320.
Haussler MR, McCain TA. Basic and clinical concepts related to vitamin D metabolism and action. Part I.N Engl J Med 1977; 297: 974–983.
Kelly DA, Summerfield JA. Haemostasis in liver disease.Semin Liver Dis 1987; 7: 182–191.
Owen OE, Reichle FA, Mozzoli MAet al. Hepatic, gut and renal substrate flux rates in patients with hepatitis and cirrhosis.J Clin Invest 1981; 76: 1209–1217.
Kabadi UM, Eisenstein AB, Tucci J. Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalisation on recovery.Am J Gastroenterol 1984; 79: 143–149.
Owen OE, Trapp VE, Richad GA. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis.J Clin Invest 1983; 72: 1821–1932.
Mullen KD, Denne SC, McCullough AJet al. Leucine metabolism in stable cirrhosis.Hepatology 1986; 6: 622–630.
Weisdorf SA, Freese DK, Fath JJet al. Amino acid abnormalities in infants with extra hepatic biliary atresia.J Peadiatr Gastro Nutr 1987; 6: 860–864.
McCullough AJ, Tavil AS. Disordered energy and protein metabolims in liver disease.Semin Liver Dis 1991; 11: 265–277.
Munroe HN. Metabolism and function of amino acids in man—Overview and synthesis. InAmino acids, Metabolism and Medical applications. Blackburn GL, Grant JP, Young VR eds. John wright and PSFG 1983: 1–12.
Ruseel WE. GH Somatomedins in the liver.Semin LIv Dis 1985; 5: 46–58.
Clemmons DR, Underwood LE. Nutritional regulation of IGF1 and IGF binding proteins.Ann Rev of Nutr 1991; 11: 393–412.
Bucuvalas JC, Cutfield W, Hornet al. Resistance to the growth promoting in metabolic effect of GH in children with chronic liver disease.J Pediatr 1990; 117: 397–402.
Bucuvalas JC, Horn JA, Carlsson Let al. Growth hormone insensitivity associated with elevated circulating growth hormone binding protein in children with Alagille’s syndrome and short stature.J Clin Endocrinol Metabol 1994; 76: 1477–1482.
Pierro A, Kovzko B, Carnielli Vet al. Resting energy expenditure is increased with infants with extra hepatic biliary atresia and cirrhosis.J Pediatr Surg 1989; 24: 534–538.
McKiernan PJ, Magnay AR, Booth IW, Kelly DA. Determinants of resting energy expenditure in childhood liver disease.J Pediatr Gastro Nutr 1994; 19: 329–366.
Baker JP, Detsky AS, Wessen DEet al. Nutritional assessment a comparison of clinical judgement and objective measurements.N Engl J Med 1983; 306: 969–972.
Goulet OJ, de Ville de Goyet J, Otte JB, Ricour C. Preoperative nutritional evaluation and support for liver transplantation in children.Transplant Proc 1987; 4: 3249–3255.
Sann L, Durand M, Picard J, Lasne Y, Bethenod M. Arm fat and muscle areas in infancy.Arch Dis Child 1988; 63: 256–260.
Meadows NJ, Till J, Leaf Aet al. Screening for intrauterine growth retardation using ratio of mid-arm curcumference to occipitiofrontal circumference.Brit Med J 1986; 292: 1039–1040.
Schoeller DA, van Santen E, Peterson DWet al. Total body water measurement in humans with 180 and 2H labelled water.Am J clin Nutr 1980; 33: 2986–2993.
Vaisman N, Pencharz PB, Koren G, Johnson JK. Comparison of oral and intravenous administration of sodium bromide for extra-cellular water measurements.Am J Clin Nutr 1987; 46: 1–4.
Davies PSW, Preece MA, Hicks CJ, Halliday D. The predication of total body water using bioelectrical impedance in children and adolescents.Ann Hum Biol 1988; 15: 237–240.
Meakins JL, Christou NV, Shizgal HM, MacLean LD. Therapeutic approaches to anergy in surgical patients Surgery and Levamisole.Ann Surg 1979; 19: 286–296.
Goodman DS. Vitamin A and retinoids in health and disease.N Engl J Med 1984; 310: 3023–3031.
Guggenheim MA, Ringel SP, Sliverman Aet al. Progressive Neuromuscular disease in children with chornic cholestasis and vitamin E deficiency; clinical and muscle biopsy findings and treatment with alcotocopherol.Ann NY Acad Sci 1982; 393; 84–93.
Bishara S, Merin S, Cooper M,et al. Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoprotinemia.Brit J Ophthalm 1982; 66: 767–770.
Alvarez F, Landrieu P, Laget Pet al. Nervous and ocular disorders in Children with cholestasis and Vitamin A and E deficinecies.Hepatology 1983; 3: 410–414.
Glasgow JFT, Thomas PS. The osteodystrophy of prolonged obstructive liver diseae in childhood.Acta Pediatr Scand 1976; 65: 57–64.
Yanofsky RA, Jackson VG, Lilly JRet al. Multiple coagulopathies of biliary atresia.Am J Haematol 1984; 16: 171–180.
Beath SV, Brook G, Kelly DAet al. Successful liver transplantation in babies under 1 year.Brit Med J 1993; 307: 825–828.
Chong SKF, Lindridge J, Moniz C, Mowat A, Exocrine pancreatic insufficiency in syndromic paucity of interlobular bile ducts.J Pediatr Gastroenterol Nutr 1989; 9: 445–449.
Beath S, Hooley I, Willis Ket al. Long chain triglyceride malabsorption and pancreatic function in children with protein energy malnutrition complicating severe liver disease.Proc Nutr Soc 1993; 52: 253A.
Sheldon GF, Perersen SR. Malnutrition and cardiopulmonary function: relation to oxygen transport.J Parent Enteral Nutr 1980; 4: 376–383.
Bidlack WR, Hamilton Smith C. The effect of nutritional factors on hepatic drug and toxicant metabolism.J Amer Diet Assoc 1984; 84: 892–898.
Moukarzel AA, Najm I, Vargas Jet al. Effective nutritional status and outcome of orthotopic liver transplantation in paediatric patinets.Transplant Proc 1990; 22: 1560–1563.
Beath SV, Booth IW, Kelly DA. Nutritional support in liver disease.Arch Dis Child 1993; 69: 545–549.
Sokol RJ, Nancy A, Butler-Simonit. Tocopheryl polyethylene glycol 1000 succinate therapy for vitamin E deficiency during chronic childhood cholestasis.J Pediatr 1987; 111: 830–836.
Marchesini G, Zolin M, Dondi Cet al. Anticatabolic effect of branched chain amino enriched solutions in patients with liver cirrhosis.Hepatology 1982; 2: 420–425.
Weber FL, Bagby BS, Licate L, Kelsen SG. Effects of branched chain amino acids on nitrogen metabolism in patients with cirrhosis.Hepatology 1990; 11: 942–950.
Blackburn GL, O’Keefe SJD. Nutrition in liver failure.Gastroenterology 1989; 97: 1049–1051.
Chin SE, Shepphard, Thomas BJet al. Nutritional support in children with end stage liver disease. A randomised crossover trial of branched chain amino acid supplement.Am J Clin Nutr 1992; 56: 158–163.
Spolidoro JV, Berquist WE, Pehlivanoglu Eet al. Growth acceleration in children after orthotopic liver transplantation.J Pediatr 1988; 112: 41–44.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kelly, D.A. Nutrition and growth in patients with chronic liver disease. Indian J Pediatr 62, 533–544 (1995). https://doi.org/10.1007/BF02761872
Issue Date:
DOI: https://doi.org/10.1007/BF02761872